Forecasted COVID-19 vaccine revenue share globally by technology 2026
In 2026, around 85 percent of all forecasted revenue generated by COVID-19 vaccines is expected to be generated by mRNA vaccines. This statistic illustrates the forecasted share of COVID-19 vaccine revenues by technology.